ClinicalTrials.govpublic full text
Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and Recovery
opioid-use disorder, extended release naltrexone, opioid dependence, recovery, health economics, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 800403
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.